EXOCRINE PANCREATIC INSUFFICIENCY (EPI)

Clinical trials for EXOCRINE PANCREATIC INSUFFICIENCY (EPI) explained in plain language.

Never miss a new study

Get alerted when new EXOCRINE PANCREATIC INSUFFICIENCY (EPI) trials appear

Sign up with your email to follow new studies for EXOCRINE PANCREATIC INSUFFICIENCY (EPI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New enzyme therapy aims to help cystic fibrosis patients digest food

Disease control Not yet recruiting

This study is testing whether a new enzyme therapy called ANG003 works as well as the standard treatment (Creon) for people with cystic fibrosis who have trouble digesting food. About 113 participants aged 12+ with cystic fibrosis and severe pancreatic insufficiency will try eith…

Matched conditions: EXOCRINE PANCREATIC INSUFFICIENCY (EPI)

Phase: PHASE2 • Sponsor: Anagram Therapeutics, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

EXOCRINE PANCREATIC INSUFFICIENCY (EPI)

Get alerted when new EXOCRINE PANCREATIC INSUFFICIENCY (EPI) trials appear

New enzyme therapy aims to help cystic fibrosis patients digest food